Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1981 Nov;78(11):7129–7133. doi: 10.1073/pnas.78.11.7129

Suppression of malignancy in human cancer cells: issues and challenges.

A B Sabin
PMCID: PMC349209  PMID: 6273913

Abstract

Analysis of the many, sometimes seemingly contradictory, reports on the partial suppression of malignancy in highly unstable rodent intraspecies and rodent--human hybrid cells emphasizes the limitations of this approach to the analysis of the basic nature of malignancy, especially in naturally occurring human cancers. During the past 5 years, Stanbridge and then Klinger reported complete suppression, not elimination, of malignancy [defined as capacity to produce progressively growing tumors in athymic (nude) mice] in stable hybrids of different human cancer cells with normal human fibroblasts or with differentiating epithelial keratinocytes and, importantly, also in stable hybrids of two parental cancers of different somatic cell origin. The nontumorigenic human hybrid cells are not rejected by some nonthymic immune mechanism of nude mice and survive in vascularized foci; the initial multiplication of these cells is stopped by some unknown proliferation controlling substance(s) to which their malignant parent(s) do not respond. The heritable properties of infinite multiplication in vitro, loss of contact inhibition, etc. remained in the nontumorigenic hybrids but, remarkably, the in vitro production of alpha human choriogonadotropin by HeLa cells was suppressed along with tumorigenicity and reappeared in the tumorigenic revertants. If it is assumed that human cancers of different somatic cell origin are caused by a loss of different specific regulatory genes, as the most recent data reviewed here suggest, the challenge is to determine in molecular terms what those missing genes are, how they function, and whether it may be possible to restore to the cancer cells what they have lost.

Full text

PDF
7129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avilès D., Jami J., Rousset J. P., Ritz E. Tumor x host cell hybrids in the mouse: chromosomes from the normal cell parent maintained in malignant hybrid tumors. J Natl Cancer Inst. 1977 May;58(5):1391–1399. doi: 10.1093/jnci/58.5.1391. [DOI] [PubMed] [Google Scholar]
  2. Bloch-Shtacher N., Sachs L. Identification of a chromosome that controls malignancy in Chinese hamster cells. J Cell Physiol. 1977 Nov;93(2):205–212. doi: 10.1002/jcp.1040930206. [DOI] [PubMed] [Google Scholar]
  3. Carney D. N., Edgell C. J., Gazdar A. F., Minna J. D. Suppression of malignancy in human lung cancer (A549/8) times mouse fibroblast (3T3-4E) somatic cell hybrids. J Natl Cancer Inst. 1979 Feb;62(2):411–415. [PubMed] [Google Scholar]
  4. Cassingena R., Suarez H. G., Lavialle C., Persuy M. A., Ermonval M. Transformation of normal diploid cells by isolated metaphase chromosomes of virus-transformed or spontaneous tumor cells. Gene. 1978 Dec;4(4):337–349. doi: 10.1016/0378-1119(78)90050-1. [DOI] [PubMed] [Google Scholar]
  5. Croce C. M., Aden D., Koprowski H. Somatic cell hybrids between mouse peritoneal macrophages and simian-virus-40-transformed human cells: II. Presence of human chromosome 7 carrying simin virus 40 genome in cells of tumors induced by hybrid cells. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1397–1400. doi: 10.1073/pnas.72.4.1397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Croce C. M., Barrick J., Linnenbach A., Koprowski H. Expression of malignancy in hybrids between normal and malignant cells. J Cell Physiol. 1979 Jun;99(3):279–285. doi: 10.1002/jcp.1040990302. [DOI] [PubMed] [Google Scholar]
  7. Der C. J., Stanbridge E. J. Alterations in the extracellular matrix organization associated with the reexpression of tumorigenicity in human cell hybrids. Int J Cancer. 1980 Oct 15;26(4):451–459. doi: 10.1002/ijc.2910260410. [DOI] [PubMed] [Google Scholar]
  8. Der C. J., Stanbridge E. J. Lack of correlation between the decreased expression of cell surface LETS protein and tumorigenicity in human cell hybrids. Cell. 1978 Dec;15(4):1241–1251. doi: 10.1016/0092-8674(78)90050-8. [DOI] [PubMed] [Google Scholar]
  9. Ephrussi B., Davidson R. L., Weiss M. C., Harris H., Klein G. Malignancy of somatic cell hybrids. Nature. 1969 Dec 27;224(5226):1314–1316. doi: 10.1038/2241314a0. [DOI] [PubMed] [Google Scholar]
  10. Gee C. J., Harris H. Tumorigenicity of cells transformed by Simian virus 40 and of hybrids between such cells and normal diploid cells. J Cell Sci. 1979 Apr;36:223–240. doi: 10.1242/jcs.36.1.223. [DOI] [PubMed] [Google Scholar]
  11. HARRIS H., WATKINS J. F. HYBRID CELLS DERIVED FROM MOUSE AND MAN: ARTIFICIAL HETEROKARYONS OF MAMMALIAN CELLS FROM DIFFERENT SPECIES. Nature. 1965 Feb 13;205:640–646. doi: 10.1038/205640a0. [DOI] [PubMed] [Google Scholar]
  12. Halaban R., Nordlund J., Francke U., Moellmann G., Eisenstadt J. M. Supermelanotic hybrids derived from mouse melanomas and normal mouse cells. Somatic Cell Genet. 1980 Jan;6(1):29–44. doi: 10.1007/BF01538694. [DOI] [PubMed] [Google Scholar]
  13. Harris H. Cell fusion and the analysis of malignancy. Proc R Soc Lond B Biol Sci. 1971 Oct 12;179(1054):1–20. doi: 10.1098/rspb.1971.0078. [DOI] [PubMed] [Google Scholar]
  14. Harris H., Miller O. J., Klein G., Worst P., Tachibana T. Suppression of malignancy by cell fusion. Nature. 1969 Jul 26;223(5204):363–368. doi: 10.1038/223363a0. [DOI] [PubMed] [Google Scholar]
  15. Howell A. N., Sager R. Tumorigenicity and its suppression in cybrids of mouse and Chinese hamster cell lines. Proc Natl Acad Sci U S A. 1978 May;75(5):2358–2362. doi: 10.1073/pnas.75.5.2358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jonasson J., Harris H. The analysis of malignancy by cell fusion. VIII. Evidence for the intervention of an extra-chromosomal element. J Cell Sci. 1977 Apr;24:255–263. doi: 10.1242/jcs.24.1.255. [DOI] [PubMed] [Google Scholar]
  17. Jonasson J., Povey S., Harris H. The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci. 1977 Apr;24:217–254. doi: 10.1242/jcs.24.1.217. [DOI] [PubMed] [Google Scholar]
  18. Kahn P., Shin S. I. Cellular tumorigenicity in nude mice. Test of associations among loss of cell-surface fibronectin, anchorage independence, and tumor-forming ability. J Cell Biol. 1979 Jul;82(1):1–16. doi: 10.1083/jcb.82.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kiessling R., Petrányi G., Klein G., Wigzell H. Non-T-cell resistance against a mouse Moloney lymphoma. Int J Cancer. 1976 Feb 15;17(2):275–281. doi: 10.1002/ijc.2910170217. [DOI] [PubMed] [Google Scholar]
  20. Klein G., Bregula U., Wiener F., Harris H. The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. J Cell Sci. 1971 May;8(3):659–672. doi: 10.1242/jcs.8.3.659. [DOI] [PubMed] [Google Scholar]
  21. Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A. 1979 May;76(5):2442–2446. doi: 10.1073/pnas.76.5.2442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klinger H. P., Baim A. S., Eun C. K., Shows T. B., Ruddle F. H. Human chromosomes which affect tumorigenicity in hybrids of diploid human with heteroploid human or rodent cells. Cytogenet Cell Genet. 1978;22(1-6):245–249. doi: 10.1159/000130947. [DOI] [PubMed] [Google Scholar]
  23. Klinger H. P. Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human X D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes. Cytogenet Cell Genet. 1980;27(4):254–266. doi: 10.1159/000131494. [DOI] [PubMed] [Google Scholar]
  24. Koprowski H., Croce C. M. Tumorigenicity of simian virus 40-transformed human cells and mouse--human hybrids in nude mice. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1142–1146. doi: 10.1073/pnas.74.3.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Koprowski H., Steplewski Z., Herlyn D., Herlyn M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3405–3409. doi: 10.1073/pnas.75.7.3405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kucherlapati R., Shin S. I. Genetic control of tumorigenicity in interspecific mammalian cell hybrids. Cell. 1979 Mar;16(3):639–648. doi: 10.1016/0092-8674(79)90037-0. [DOI] [PubMed] [Google Scholar]
  27. Minato N., Bloom B. R., Jones C., Holland J., Reid L. M. Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med. 1979 May 1;149(5):1117–1133. doi: 10.1084/jem.149.5.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ozer H. L., Jha K. K. Malignancy and transformation: expression in somatic cell hybrids and variants. Adv Cancer Res. 1977;25:53–93. doi: 10.1016/s0065-230x(08)60632-6. [DOI] [PubMed] [Google Scholar]
  29. Peehl D. M., Stanbridge E. J. Characterization of human keratinocyte X HeLa somatic cell hybrids. Int J Cancer. 1981 May 15;27(5):625–635. doi: 10.1002/ijc.2910270509. [DOI] [PubMed] [Google Scholar]
  30. Reid L. M., Jones C. L., Holland J. Virus carrier state suppresses tumorigenicity of tumor cells in athymic (nude) mice. J Gen Virol. 1979 Mar;42(3):609–614. doi: 10.1099/0022-1317-42-3-609. [DOI] [PubMed] [Google Scholar]
  31. Shih C., Padhy L. C., Murray M., Weinberg R. A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature. 1981 Mar 19;290(5803):261–264. doi: 10.1038/290261a0. [DOI] [PubMed] [Google Scholar]
  32. Shih C., Shilo B. Z., Goldfarb M. P., Dannenberg A., Weinberg R. A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5714–5718. doi: 10.1073/pnas.76.11.5714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Stanbridge E. J., Ceredig R. Growth-regulatory control of human cell hybrids in nude mice. Cancer Res. 1981 Feb;41(2):573–580. [PubMed] [Google Scholar]
  34. Stanbridge E. J. Suppression of malignancy in human cells. Nature. 1976 Mar 4;260(5546):17–20. doi: 10.1038/260017a0. [DOI] [PubMed] [Google Scholar]
  35. Stanbridge E. J., Wilkinson J. Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1466–1469. doi: 10.1073/pnas.75.3.1466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stiles C. D., Desmond W., Jr, Sato G., Saier M. H., Jr Failure of human cells transformed by simian virus 40 to form tumors in athymic nude mice. Proc Natl Acad Sci U S A. 1975 Dec;72(12):4971–4975. doi: 10.1073/pnas.72.12.4971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Warner N. L., Woodruff M. F., Burton R. C. Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice. Int J Cancer. 1977 Jul 15;20(1):146–155. doi: 10.1002/ijc.2910200122. [DOI] [PubMed] [Google Scholar]
  38. Ziegler M. L. Phenotypic expression of malignancy in hybrid and cybrid mouse cells. Somatic Cell Genet. 1978 Jul;4(4):477–489. doi: 10.1007/BF01538868. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES